GlassScriptPhysician profile
Gregory D Dietrich
NPI 1306831698
$41,537.27
in general payments reported to CMS, 2019-2025
13 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $4,472 · 2021: $3,639 · 2022: $2,547 · 2023: $167 · 2024: $436 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovis Surgical Technologies, INC. | $28,579.55 | 2019 | |
| Kyocera Medical Technologies, INC. | $10,363.30 | 2020-2022 | |
| Nuvasive, INC. | $1,491.23 | 2019 | |
| Depuy Synthes Sales INC. | $715.31 | 2020-2025 | Teligen, Attune, Velys |
| Stryker Corporation | $152.85 | 2019-2024 | Mako |
| Ferring Pharmaceuticals INC. | $60.77 | 2021-2025 | Euflexxa |
| Sanara Medtech INC. | $34.97 | 2023 | Celleraterx |
| Seaspine Orthopedics Corporation | $32.74 | 2022 | |
| Sawtooth Surgical Solutions INC | $32.37 | 2025 | |
| Globus Medical, INC. | $24.34 | 2025 | Nvm5 |
| Heron Therapeutics, INC. | $23.39 | 2024 | Zynrelef |
| Summit Surgical Corp. | $16.70 | 2023 | |
| Brainlab, INC. | $9.75 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$436,696.81 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Dietrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.